Abstract
Nrf2, a redox sensitive transcription factor, plays a pivotal role in redox homeostasis during oxidative stress. Nrf2 is sequestered in cytosol by an inhibitory protein Keap1 which causes its proteasomal degradation. In response to electrophilic and oxidative stress, Nrf2 is activated, translocates to nucleus, binds to antioxidant response element (ARE), thus upregulates a battery of antioxidant and detoxifying genes. This function of Nrf2 can be significant in the treatment of diseases, such as cancer, neurodegenerative, cardiovascular and pulmonary complications, where oxidative stress causes Nrf2 derangement. Nrf2 upregulating potential of phytochemicals has been explored, in facilitating cure for various ailments while, in cancer cells, Nrf2 upregulation causes chemoresistance. Therefore, Nrf2 emerges as a key regulator in oxidative stress-mediated diseases and Nrf2 silencing can open avenues in cancer treatment. This review summarizes Nrf2-ARE stress response mechanism and its role as a control point in oxidative stress-induced cellular dysfunctions including chronic inflammatory diseases.
Acknowledgements
The author's are grateful to Director, IITR for his support in this work. We thank Dr Hongwei Yao (Department of Environmental Medicine, University of Rochester Medical Center, Rochester, NY, USA) for useful comments.
Declaration of interest: The authors are also indebted to the Council of Scientific and Industrial Research (CSIR) for the grant of Fellowships and support under suprainstitutional project SIP-08. Thanks are also due to the Publication review committee of IITR for allocating manuscript communication number 2770.
This paper was first published online on Early Online on 11 August 2010.